Clinical trial / 2014
Oral beta-glucan failed to alter innate immune responses in healthy men.
A randomized open-label pilot trial evaluated 15 healthy male volunteers assigned to 1,000 mg of oral beta-glucan daily (n = 10) or control (n = 5) for 7 days. Serum beta-glucan concentrations were barely detectable in participants across all time points. Ingestion of oral beta-glucan did not affect leukocyte cytokine production or microbicidal activity.
- Study type
- Randomized open-label trial
- Who was studied
- 15 healthy male volunteers
- What was measured
- Serum beta-glucan levels, cytokine production, and microbicidal activity
THE PAPER
The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.
Leentjens J, Quintin J, Gerretsen J, Kox M, Pickkers P, Netea MG. PLoS One, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.